Drug Efficacy

Weight Loss Injections Postpartum Depression Treatments Obesity Treatment Zepbound Weight Loss Drugs Flu Treatments Workplace Health Weight Loss Patient Discontinuation Patient Outcomes CagriSema Transfusion Independence Best-in-Class Medicines Survival Data Zepbound Studies Memory Improvement

10 ARTICLES

4w ago

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

4 ARTICLES

8mo ago

Randomized Trial Finds Solriamfetol Improves Alertness in Early-Morning Shift Workers

4 ARTICLES

8mo ago

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping